This occurred along with the recovery of the NO-level to normal values through BPC 157 therapy (regularly, the NO-level decreased during ischemia and increased during reperfusion) and counteraction to normal values of the increased MDA values (increased in ischemia and even more in reperfusion) [194] (see Section 3.2)
The FDA confirmed that BPC-157 and TB-500 are among the seven peptides under review, alongside five others
Ilic S, Drmic D, Franjic S, Kolenc D, Coric M, Brcic L, Klicek R, Radic B, Sever M, Djuzel V, Filipovic M
Romania (EU)
Between 12% and 58% of unregulated supplement and research chemical products have been found to be contaminated with other substances, according to published literature [2]